Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/1703269.pdf
Reference21 articles.
1. Storb R, Gluckman E, Thomas ED et al. Treatment of established human graft-vs-host disease by antithymocyte globulin Blood 1974 44: 56–75
2. Doney KC, Weiden PL, Storb R, Thomas ED . Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroid Am J Hematol 1981 11: 1–8
3. Deeg HJ, Loughran TP, Storb R et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone Transplantation 1985 40: 162–166
4. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment Blood 1990 76: 1464–1472
5. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment Blood 1991 77: 1821–1828
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature;Expert Opinion on Investigational Drugs;2024-07-09
2. Graft Versus Host Disease: Management of Acute and Chronic Disease;Contemporary Bone Marrow Transplantation;2021
3. Graft Versus Host Disease: Management of Acute and Chronic Disease;Contemporary Bone Marrow Transplantation;2020-12-19
4. Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease;Journal of Experimental Pharmacology;2020-11
Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
5. Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease;Expert Opinion on Investigational Drugs;2020-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3